富满微：2025年前三季度净利润约-5947万元

Group 1 - Company Fuman Micro reported a revenue of approximately 592 million yuan for the first three quarters of 2025, representing a year-on-year increase of 19.32% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 59.47 million yuan, with a basic earnings per share loss of 0.27 yuan [1] - As of the report date, Fuman Micro's market capitalization was 8 billion yuan [2] Group 2 - The Chinese innovative drug sector has generated 80 billion USD in overseas licensing deals this year [2] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [2]